Oct
2026
Fiera Milano, Italy
Visit us
stand 4J89, API
Nantong Jinghua Pharmaceutical co., Ltd.
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 4J89, API
Products Featured at CPHI Milan 2026
-
Product Letermovir
use in prophylaxis of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplant patients. It is the first of a new class of CMV anti-infectives called DNA terminase complex inhibitors. -
Product INDOCYANINE GREEN
Indocyanine green is a Diagnostic Dye. The mechanism of action of indocyanine green is as a Dye. -
Product Phenobarbital
There are CEP and US DMF for this product, our main markets are regulatory market, such South America and European.
-
Product Fluorouracil
There are CEP certificate and US DMF, approved by TGA, FDA and COFERPIS.
-
Product Phenylbutazone
There are CEP certificate and US VMF, approved by FDA for more than three years. Our main markets are European and US.



